SEC Form 4 · accession 0001724311-26-000013
Denali Therapeutics Inc. · DNLI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Alexander O. Schuth
Officer — COFO and Secretary
Period of report
Aug 11, 2026
Accepted (ET)
Aug 13, 2026 · 5:01 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001714899
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2,F3 | Aug 11, 2026 | S | 2,857 | $25.07 | D | 281,763 | D | |
| Common StockF4 | holding | — | — | — | 523,749 | I | See footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares sold to satisfy the tax obligations by the Reporting Person in connection with the settlement of previously vested RSUs.
- F2Includes 135,475 Unvested RSUs.
- F3Includes 1,792 shares acquired under the ESPP Purchase on June 1, 2026.
- F4The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee.